nodes	percent_of_prediction	percent_of_DWPC	metapath
Topotecan—Irinotecan—lung cancer	0.299	1	CrCtD
Topotecan—Topoisomerase Inhibitors—Teniposide—lung cancer	0.126	0.366	CiPCiCtD
Topotecan—TOP1—lung cancer	0.105	0.712	CbGaD
Topotecan—Topoisomerase Inhibitors—Irinotecan—lung cancer	0.0956	0.278	CiPCiCtD
Topotecan—Topoisomerase Inhibitors—Etoposide—lung cancer	0.075	0.218	CiPCiCtD
Topotecan—TOP1MT—Irinotecan—lung cancer	0.0608	0.395	CbGbCtD
Topotecan—Topoisomerase Inhibitors—Doxorubicin—lung cancer	0.0478	0.139	CiPCiCtD
Topotecan—TOP1—Irinotecan—lung cancer	0.0349	0.227	CbGbCtD
Topotecan—ABCG2—lung cancer	0.03	0.204	CbGaD
Topotecan—ABCB1—lung cancer	0.0125	0.0848	CbGaD
Topotecan—ABCG2—Gefitinib—lung cancer	0.0062	0.0403	CbGbCtD
Topotecan—ABCG2—Teniposide—lung cancer	0.00601	0.039	CbGbCtD
Topotecan—ABCG2—Erlotinib—lung cancer	0.00366	0.0238	CbGbCtD
Topotecan—ABCG2—Paclitaxel—lung cancer	0.00335	0.0218	CbGbCtD
Topotecan—ABCG2—Irinotecan—lung cancer	0.00331	0.0215	CbGbCtD
Topotecan—ABCG2—Cisplatin—lung cancer	0.0027	0.0175	CbGbCtD
Topotecan—ABCG2—Etoposide—lung cancer	0.00265	0.0172	CbGbCtD
Topotecan—ABCG2—Docetaxel—lung cancer	0.00243	0.0158	CbGbCtD
Topotecan—ABCB1—Gefitinib—lung cancer	0.00223	0.0145	CbGbCtD
Topotecan—ABCG2—Doxorubicin—lung cancer	0.00181	0.0117	CbGbCtD
Topotecan—ABCG2—Methotrexate—lung cancer	0.00175	0.0114	CbGbCtD
Topotecan—ABCB1—Vinorelbine—lung cancer	0.00172	0.0112	CbGbCtD
Topotecan—ABCB1—Crizotinib—lung cancer	0.00137	0.0089	CbGbCtD
Topotecan—CYP3A4—Gefitinib—lung cancer	0.00134	0.0087	CbGbCtD
Topotecan—ABCB1—Gemcitabine—lung cancer	0.00134	0.0087	CbGbCtD
Topotecan—ABCB1—Erlotinib—lung cancer	0.00132	0.00859	CbGbCtD
Topotecan—CYP3A4—Teniposide—lung cancer	0.0013	0.00844	CbGbCtD
Topotecan—ABCB1—Paclitaxel—lung cancer	0.00121	0.00786	CbGbCtD
Topotecan—ABCB1—Irinotecan—lung cancer	0.00119	0.00775	CbGbCtD
Topotecan—ABCB1—Vinblastine—lung cancer	0.00106	0.00689	CbGbCtD
Topotecan—CYP3A4—Vinorelbine—lung cancer	0.00103	0.0067	CbGbCtD
Topotecan—ABCB1—Cisplatin—lung cancer	0.000973	0.00632	CbGbCtD
Topotecan—ABCB1—Etoposide—lung cancer	0.000956	0.00621	CbGbCtD
Topotecan—ABCB1—Docetaxel—lung cancer	0.000875	0.00568	CbGbCtD
Topotecan—CYP3A4—Crizotinib—lung cancer	0.000821	0.00533	CbGbCtD
Topotecan—CYP3A4—Erlotinib—lung cancer	0.000792	0.00514	CbGbCtD
Topotecan—TOP1MT—respiratory system—lung cancer	0.000785	0.188	CbGeAlD
Topotecan—CYP3A4—Paclitaxel—lung cancer	0.000725	0.00471	CbGbCtD
Topotecan—CYP3A4—Irinotecan—lung cancer	0.000715	0.00465	CbGbCtD
Topotecan—ABCB1—Doxorubicin—lung cancer	0.000652	0.00424	CbGbCtD
Topotecan—CYP3A4—Vinblastine—lung cancer	0.000636	0.00413	CbGbCtD
Topotecan—ABCB1—Methotrexate—lung cancer	0.000632	0.0041	CbGbCtD
Topotecan—Irinotecan—TOP1—lung cancer	0.000628	0.49	CrCbGaD
Topotecan—TOP1—mammary gland—lung cancer	0.000622	0.149	CbGeAlD
Topotecan—CYP3A4—Etoposide—lung cancer	0.000573	0.00372	CbGbCtD
Topotecan—CYP3A4—Docetaxel—lung cancer	0.000524	0.0034	CbGbCtD
Topotecan—TOP1MT—lung—lung cancer	0.000417	0.1	CbGeAlD
Topotecan—CYP3A4—Doxorubicin—lung cancer	0.000391	0.00254	CbGbCtD
Topotecan—TOP1—bronchus—lung cancer	0.000341	0.0818	CbGeAlD
Topotecan—Irinotecan—UGT1A1—lung cancer	0.00032	0.25	CrCbGaD
Topotecan—TOP1—trachea—lung cancer	0.000306	0.0735	CbGeAlD
Topotecan—TOP1—cardiac atrium—lung cancer	0.000288	0.069	CbGeAlD
Topotecan—TOP1MT—lymph node—lung cancer	0.000285	0.0684	CbGeAlD
Topotecan—TOP1—bone marrow—lung cancer	0.000243	0.0583	CbGeAlD
Topotecan—TOP1—lung—lung cancer	0.00022	0.0528	CbGeAlD
Topotecan—Irinotecan—ABCG2—lung cancer	0.00018	0.14	CrCbGaD
Topotecan—TOP1—lymph node—lung cancer	0.00015	0.0361	CbGeAlD
Topotecan—ABCG2—bone marrow—lung cancer	8.62e-05	0.0207	CbGeAlD
Topotecan—Irinotecan—ALB—lung cancer	7.84e-05	0.0612	CrCbGaD
Topotecan—ABCG2—lung—lung cancer	7.81e-05	0.0187	CbGeAlD
Topotecan—Irinotecan—ABCB1—lung cancer	7.49e-05	0.0584	CrCbGaD
Topotecan—ABCB1—respiratory system—lung cancer	7.25e-05	0.0174	CbGeAlD
Topotecan—ABCB1—epithelium—lung cancer	6.06e-05	0.0145	CbGeAlD
Topotecan—ABCB1—trachea—lung cancer	5.36e-05	0.0128	CbGeAlD
Topotecan—ABCG2—lymph node—lung cancer	5.34e-05	0.0128	CbGeAlD
Topotecan—ABCB1—bone marrow—lung cancer	4.25e-05	0.0102	CbGeAlD
Topotecan—ABCB1—lung—lung cancer	3.85e-05	0.00923	CbGeAlD
Topotecan—ABCB1—lymph node—lung cancer	2.63e-05	0.00631	CbGeAlD
Topotecan—Dizziness—Vinorelbine—lung cancer	1.71e-05	0.000433	CcSEcCtD
Topotecan—Nervous system disorder—Paclitaxel—lung cancer	1.71e-05	0.000432	CcSEcCtD
Topotecan—Thrombocytopenia—Paclitaxel—lung cancer	1.7e-05	0.000432	CcSEcCtD
Topotecan—Anorexia—Etoposide—lung cancer	1.69e-05	0.000429	CcSEcCtD
Topotecan—Skin disorder—Paclitaxel—lung cancer	1.69e-05	0.000428	CcSEcCtD
Topotecan—Abdominal pain—Irinotecan—lung cancer	1.69e-05	0.000427	CcSEcCtD
Topotecan—Body temperature increased—Irinotecan—lung cancer	1.69e-05	0.000427	CcSEcCtD
Topotecan—Aspartate aminotransferase increased—Doxorubicin—lung cancer	1.69e-05	0.000427	CcSEcCtD
Topotecan—Decreased appetite—Cisplatin—lung cancer	1.68e-05	0.000427	CcSEcCtD
Topotecan—Hyperhidrosis—Paclitaxel—lung cancer	1.68e-05	0.000426	CcSEcCtD
Topotecan—Pneumonia—Methotrexate—lung cancer	1.68e-05	0.000425	CcSEcCtD
Topotecan—Gastrointestinal disorder—Cisplatin—lung cancer	1.67e-05	0.000424	CcSEcCtD
Topotecan—Anaemia—Docetaxel—lung cancer	1.67e-05	0.000423	CcSEcCtD
Topotecan—Infestation—Methotrexate—lung cancer	1.67e-05	0.000422	CcSEcCtD
Topotecan—Infestation NOS—Methotrexate—lung cancer	1.67e-05	0.000422	CcSEcCtD
Topotecan—Anorexia—Paclitaxel—lung cancer	1.66e-05	0.00042	CcSEcCtD
Topotecan—Pain—Cisplatin—lung cancer	1.66e-05	0.00042	CcSEcCtD
Topotecan—Alanine aminotransferase increased—Doxorubicin—lung cancer	1.65e-05	0.000418	CcSEcCtD
Topotecan—Vomiting—Vinorelbine—lung cancer	1.65e-05	0.000417	CcSEcCtD
Topotecan—Body temperature increased—Gemcitabine—lung cancer	1.64e-05	0.000416	CcSEcCtD
Topotecan—Rash—Vinorelbine—lung cancer	1.63e-05	0.000413	CcSEcCtD
Topotecan—Dermatitis—Vinorelbine—lung cancer	1.63e-05	0.000413	CcSEcCtD
Topotecan—Stomatitis—Methotrexate—lung cancer	1.62e-05	0.000412	CcSEcCtD
Topotecan—Headache—Vinorelbine—lung cancer	1.62e-05	0.000411	CcSEcCtD
Topotecan—Leukopenia—Docetaxel—lung cancer	1.62e-05	0.00041	CcSEcCtD
Topotecan—Sweating—Methotrexate—lung cancer	1.6e-05	0.000405	CcSEcCtD
Topotecan—Feeling abnormal—Cisplatin—lung cancer	1.6e-05	0.000404	CcSEcCtD
Topotecan—Paraesthesia—Etoposide—lung cancer	1.59e-05	0.000404	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Paclitaxel—lung cancer	1.59e-05	0.000402	CcSEcCtD
Topotecan—Dyspnoea—Etoposide—lung cancer	1.58e-05	0.000401	CcSEcCtD
Topotecan—Cough—Docetaxel—lung cancer	1.58e-05	0.000399	CcSEcCtD
Topotecan—Hepatobiliary disease—Methotrexate—lung cancer	1.58e-05	0.000399	CcSEcCtD
Topotecan—Epistaxis—Methotrexate—lung cancer	1.57e-05	0.000398	CcSEcCtD
Topotecan—Hypersensitivity—Irinotecan—lung cancer	1.57e-05	0.000398	CcSEcCtD
Topotecan—Paraesthesia—Paclitaxel—lung cancer	1.56e-05	0.000396	CcSEcCtD
Topotecan—Dyspnoea—Paclitaxel—lung cancer	1.55e-05	0.000393	CcSEcCtD
Topotecan—Decreased appetite—Etoposide—lung cancer	1.54e-05	0.000391	CcSEcCtD
Topotecan—Chest pain—Docetaxel—lung cancer	1.54e-05	0.00039	CcSEcCtD
Topotecan—Arthralgia—Docetaxel—lung cancer	1.54e-05	0.00039	CcSEcCtD
Topotecan—Myalgia—Docetaxel—lung cancer	1.54e-05	0.00039	CcSEcCtD
Topotecan—Pancytopenia—Doxorubicin—lung cancer	1.54e-05	0.000389	CcSEcCtD
Topotecan—Nausea—Vinorelbine—lung cancer	1.54e-05	0.000389	CcSEcCtD
Topotecan—Gastrointestinal disorder—Etoposide—lung cancer	1.53e-05	0.000388	CcSEcCtD
Topotecan—Dyspepsia—Paclitaxel—lung cancer	1.53e-05	0.000388	CcSEcCtD
Topotecan—Body temperature increased—Cisplatin—lung cancer	1.53e-05	0.000388	CcSEcCtD
Topotecan—Asthenia—Irinotecan—lung cancer	1.53e-05	0.000388	CcSEcCtD
Topotecan—Fatigue—Etoposide—lung cancer	1.53e-05	0.000388	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	1.53e-05	0.000387	CcSEcCtD
Topotecan—Constipation—Etoposide—lung cancer	1.52e-05	0.000384	CcSEcCtD
Topotecan—Pain—Etoposide—lung cancer	1.52e-05	0.000384	CcSEcCtD
Topotecan—Neutropenia—Doxorubicin—lung cancer	1.51e-05	0.000383	CcSEcCtD
Topotecan—Decreased appetite—Paclitaxel—lung cancer	1.51e-05	0.000383	CcSEcCtD
Topotecan—Haemoglobin—Methotrexate—lung cancer	1.5e-05	0.000381	CcSEcCtD
Topotecan—Gastrointestinal disorder—Paclitaxel—lung cancer	1.5e-05	0.000381	CcSEcCtD
Topotecan—Fatigue—Paclitaxel—lung cancer	1.5e-05	0.00038	CcSEcCtD
Topotecan—Haemorrhage—Methotrexate—lung cancer	1.5e-05	0.000379	CcSEcCtD
Topotecan—Asthenia—Gemcitabine—lung cancer	1.49e-05	0.000378	CcSEcCtD
Topotecan—Pain—Paclitaxel—lung cancer	1.49e-05	0.000377	CcSEcCtD
Topotecan—Constipation—Paclitaxel—lung cancer	1.49e-05	0.000377	CcSEcCtD
Topotecan—Pharyngitis—Methotrexate—lung cancer	1.49e-05	0.000376	CcSEcCtD
Topotecan—Anaphylactic shock—Docetaxel—lung cancer	1.48e-05	0.000374	CcSEcCtD
Topotecan—Weight increased—Doxorubicin—lung cancer	1.47e-05	0.000373	CcSEcCtD
Topotecan—Pruritus—Gemcitabine—lung cancer	1.47e-05	0.000372	CcSEcCtD
Topotecan—Infection—Docetaxel—lung cancer	1.47e-05	0.000371	CcSEcCtD
Topotecan—Feeling abnormal—Etoposide—lung cancer	1.46e-05	0.00037	CcSEcCtD
Topotecan—Diarrhoea—Irinotecan—lung cancer	1.46e-05	0.00037	CcSEcCtD
Topotecan—Pneumonia—Doxorubicin—lung cancer	1.45e-05	0.000368	CcSEcCtD
Topotecan—Gastrointestinal pain—Etoposide—lung cancer	1.45e-05	0.000368	CcSEcCtD
Topotecan—Nervous system disorder—Docetaxel—lung cancer	1.45e-05	0.000366	CcSEcCtD
Topotecan—Thrombocytopenia—Docetaxel—lung cancer	1.44e-05	0.000366	CcSEcCtD
Topotecan—Infestation—Doxorubicin—lung cancer	1.44e-05	0.000366	CcSEcCtD
Topotecan—Infestation NOS—Doxorubicin—lung cancer	1.44e-05	0.000366	CcSEcCtD
Topotecan—Feeling abnormal—Paclitaxel—lung cancer	1.43e-05	0.000363	CcSEcCtD
Topotecan—Skin disorder—Docetaxel—lung cancer	1.43e-05	0.000363	CcSEcCtD
Topotecan—Hypersensitivity—Cisplatin—lung cancer	1.43e-05	0.000362	CcSEcCtD
Topotecan—Gastrointestinal pain—Paclitaxel—lung cancer	1.42e-05	0.00036	CcSEcCtD
Topotecan—Diarrhoea—Gemcitabine—lung cancer	1.42e-05	0.00036	CcSEcCtD
Topotecan—Neuropathy peripheral—Doxorubicin—lung cancer	1.41e-05	0.000358	CcSEcCtD
Topotecan—Dizziness—Irinotecan—lung cancer	1.41e-05	0.000357	CcSEcCtD
Topotecan—Urticaria—Etoposide—lung cancer	1.41e-05	0.000357	CcSEcCtD
Topotecan—Stomatitis—Doxorubicin—lung cancer	1.41e-05	0.000356	CcSEcCtD
Topotecan—Anorexia—Docetaxel—lung cancer	1.41e-05	0.000356	CcSEcCtD
Topotecan—Body temperature increased—Etoposide—lung cancer	1.4e-05	0.000355	CcSEcCtD
Topotecan—Abdominal pain—Etoposide—lung cancer	1.4e-05	0.000355	CcSEcCtD
Topotecan—Asthenia—Cisplatin—lung cancer	1.39e-05	0.000352	CcSEcCtD
Topotecan—Sweating—Doxorubicin—lung cancer	1.38e-05	0.000351	CcSEcCtD
Topotecan—Urticaria—Paclitaxel—lung cancer	1.38e-05	0.00035	CcSEcCtD
Topotecan—Abdominal pain—Paclitaxel—lung cancer	1.38e-05	0.000348	CcSEcCtD
Topotecan—Body temperature increased—Paclitaxel—lung cancer	1.38e-05	0.000348	CcSEcCtD
Topotecan—Hepatobiliary disease—Doxorubicin—lung cancer	1.37e-05	0.000346	CcSEcCtD
Topotecan—Epistaxis—Doxorubicin—lung cancer	1.36e-05	0.000345	CcSEcCtD
Topotecan—Angiopathy—Methotrexate—lung cancer	1.36e-05	0.000344	CcSEcCtD
Topotecan—Vomiting—Irinotecan—lung cancer	1.36e-05	0.000344	CcSEcCtD
Topotecan—Immune system disorder—Methotrexate—lung cancer	1.35e-05	0.000342	CcSEcCtD
Topotecan—Mediastinal disorder—Methotrexate—lung cancer	1.35e-05	0.000342	CcSEcCtD
Topotecan—Rash—Irinotecan—lung cancer	1.35e-05	0.000341	CcSEcCtD
Topotecan—Dermatitis—Irinotecan—lung cancer	1.34e-05	0.00034	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Docetaxel—lung cancer	1.34e-05	0.00034	CcSEcCtD
Topotecan—Chills—Methotrexate—lung cancer	1.34e-05	0.00034	CcSEcCtD
Topotecan—Headache—Irinotecan—lung cancer	1.34e-05	0.000339	CcSEcCtD
Topotecan—Diarrhoea—Cisplatin—lung cancer	1.33e-05	0.000336	CcSEcCtD
Topotecan—Paraesthesia—Docetaxel—lung cancer	1.32e-05	0.000336	CcSEcCtD
Topotecan—Alopecia—Methotrexate—lung cancer	1.32e-05	0.000335	CcSEcCtD
Topotecan—Vomiting—Gemcitabine—lung cancer	1.32e-05	0.000335	CcSEcCtD
Topotecan—Dyspnoea—Docetaxel—lung cancer	1.32e-05	0.000333	CcSEcCtD
Topotecan—Rash—Gemcitabine—lung cancer	1.31e-05	0.000332	CcSEcCtD
Topotecan—Dermatitis—Gemcitabine—lung cancer	1.31e-05	0.000332	CcSEcCtD
Topotecan—Hypersensitivity—Etoposide—lung cancer	1.31e-05	0.000331	CcSEcCtD
Topotecan—Malnutrition—Methotrexate—lung cancer	1.3e-05	0.00033	CcSEcCtD
Topotecan—Haemoglobin—Doxorubicin—lung cancer	1.3e-05	0.00033	CcSEcCtD
Topotecan—Headache—Gemcitabine—lung cancer	1.3e-05	0.00033	CcSEcCtD
Topotecan—Rhinitis—Doxorubicin—lung cancer	1.3e-05	0.000329	CcSEcCtD
Topotecan—Dyspepsia—Docetaxel—lung cancer	1.3e-05	0.000329	CcSEcCtD
Topotecan—Haemorrhage—Doxorubicin—lung cancer	1.3e-05	0.000328	CcSEcCtD
Topotecan—Hypoaesthesia—Doxorubicin—lung cancer	1.29e-05	0.000327	CcSEcCtD
Topotecan—Pharyngitis—Doxorubicin—lung cancer	1.29e-05	0.000326	CcSEcCtD
Topotecan—Decreased appetite—Docetaxel—lung cancer	1.28e-05	0.000325	CcSEcCtD
Topotecan—Hypersensitivity—Paclitaxel—lung cancer	1.28e-05	0.000325	CcSEcCtD
Topotecan—Gastrointestinal disorder—Docetaxel—lung cancer	1.27e-05	0.000323	CcSEcCtD
Topotecan—Asthenia—Etoposide—lung cancer	1.27e-05	0.000323	CcSEcCtD
Topotecan—Fatigue—Docetaxel—lung cancer	1.27e-05	0.000322	CcSEcCtD
Topotecan—Nausea—Irinotecan—lung cancer	1.27e-05	0.000321	CcSEcCtD
Topotecan—Pain—Docetaxel—lung cancer	1.26e-05	0.00032	CcSEcCtD
Topotecan—Constipation—Docetaxel—lung cancer	1.26e-05	0.00032	CcSEcCtD
Topotecan—Back pain—Methotrexate—lung cancer	1.26e-05	0.000319	CcSEcCtD
Topotecan—Pruritus—Etoposide—lung cancer	1.26e-05	0.000318	CcSEcCtD
Topotecan—Asthenia—Paclitaxel—lung cancer	1.25e-05	0.000316	CcSEcCtD
Topotecan—Nausea—Gemcitabine—lung cancer	1.23e-05	0.000313	CcSEcCtD
Topotecan—Vomiting—Cisplatin—lung cancer	1.23e-05	0.000312	CcSEcCtD
Topotecan—Pruritus—Paclitaxel—lung cancer	1.23e-05	0.000312	CcSEcCtD
Topotecan—Rash—Cisplatin—lung cancer	1.22e-05	0.000309	CcSEcCtD
Topotecan—Dermatitis—Cisplatin—lung cancer	1.22e-05	0.000309	CcSEcCtD
Topotecan—Feeling abnormal—Docetaxel—lung cancer	1.22e-05	0.000308	CcSEcCtD
Topotecan—Diarrhoea—Etoposide—lung cancer	1.21e-05	0.000308	CcSEcCtD
Topotecan—Ill-defined disorder—Methotrexate—lung cancer	1.21e-05	0.000306	CcSEcCtD
Topotecan—Gastrointestinal pain—Docetaxel—lung cancer	1.21e-05	0.000306	CcSEcCtD
Topotecan—Anaemia—Methotrexate—lung cancer	1.2e-05	0.000305	CcSEcCtD
Topotecan—Diarrhoea—Paclitaxel—lung cancer	1.19e-05	0.000302	CcSEcCtD
Topotecan—Angiopathy—Doxorubicin—lung cancer	1.18e-05	0.000298	CcSEcCtD
Topotecan—Malaise—Methotrexate—lung cancer	1.17e-05	0.000298	CcSEcCtD
Topotecan—Dizziness—Etoposide—lung cancer	1.17e-05	0.000297	CcSEcCtD
Topotecan—Immune system disorder—Doxorubicin—lung cancer	1.17e-05	0.000296	CcSEcCtD
Topotecan—Mediastinal disorder—Doxorubicin—lung cancer	1.17e-05	0.000296	CcSEcCtD
Topotecan—Body temperature increased—Docetaxel—lung cancer	1.17e-05	0.000295	CcSEcCtD
Topotecan—Abdominal pain—Docetaxel—lung cancer	1.17e-05	0.000295	CcSEcCtD
Topotecan—Leukopenia—Methotrexate—lung cancer	1.17e-05	0.000295	CcSEcCtD
Topotecan—Chills—Doxorubicin—lung cancer	1.16e-05	0.000294	CcSEcCtD
Topotecan—Dizziness—Paclitaxel—lung cancer	1.15e-05	0.000291	CcSEcCtD
Topotecan—Nausea—Cisplatin—lung cancer	1.15e-05	0.000291	CcSEcCtD
Topotecan—Alopecia—Doxorubicin—lung cancer	1.14e-05	0.00029	CcSEcCtD
Topotecan—Cough—Methotrexate—lung cancer	1.14e-05	0.000288	CcSEcCtD
Topotecan—Vomiting—Etoposide—lung cancer	1.13e-05	0.000286	CcSEcCtD
Topotecan—Malnutrition—Doxorubicin—lung cancer	1.13e-05	0.000286	CcSEcCtD
Topotecan—Rash—Etoposide—lung cancer	1.12e-05	0.000283	CcSEcCtD
Topotecan—Dermatitis—Etoposide—lung cancer	1.12e-05	0.000283	CcSEcCtD
Topotecan—Headache—Etoposide—lung cancer	1.11e-05	0.000282	CcSEcCtD
Topotecan—Arthralgia—Methotrexate—lung cancer	1.11e-05	0.000281	CcSEcCtD
Topotecan—Chest pain—Methotrexate—lung cancer	1.11e-05	0.000281	CcSEcCtD
Topotecan—Myalgia—Methotrexate—lung cancer	1.11e-05	0.000281	CcSEcCtD
Topotecan—Vomiting—Paclitaxel—lung cancer	1.11e-05	0.00028	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	1.1e-05	0.000279	CcSEcCtD
Topotecan—Rash—Paclitaxel—lung cancer	1.1e-05	0.000278	CcSEcCtD
Topotecan—Dermatitis—Paclitaxel—lung cancer	1.1e-05	0.000278	CcSEcCtD
Topotecan—Discomfort—Methotrexate—lung cancer	1.1e-05	0.000278	CcSEcCtD
Topotecan—Back pain—Doxorubicin—lung cancer	1.09e-05	0.000276	CcSEcCtD
Topotecan—Headache—Paclitaxel—lung cancer	1.09e-05	0.000276	CcSEcCtD
Topotecan—Hypersensitivity—Docetaxel—lung cancer	1.09e-05	0.000275	CcSEcCtD
Topotecan—Muscle spasms—Doxorubicin—lung cancer	1.08e-05	0.000275	CcSEcCtD
Topotecan—Anaphylactic shock—Methotrexate—lung cancer	1.06e-05	0.000269	CcSEcCtD
Topotecan—Asthenia—Docetaxel—lung cancer	1.06e-05	0.000268	CcSEcCtD
Topotecan—Infection—Methotrexate—lung cancer	1.06e-05	0.000268	CcSEcCtD
Topotecan—Nausea—Etoposide—lung cancer	1.05e-05	0.000267	CcSEcCtD
Topotecan—Ill-defined disorder—Doxorubicin—lung cancer	1.05e-05	0.000265	CcSEcCtD
Topotecan—Pruritus—Docetaxel—lung cancer	1.04e-05	0.000264	CcSEcCtD
Topotecan—Nervous system disorder—Methotrexate—lung cancer	1.04e-05	0.000264	CcSEcCtD
Topotecan—Anaemia—Doxorubicin—lung cancer	1.04e-05	0.000264	CcSEcCtD
Topotecan—Thrombocytopenia—Methotrexate—lung cancer	1.04e-05	0.000264	CcSEcCtD
Topotecan—Nausea—Paclitaxel—lung cancer	1.03e-05	0.000262	CcSEcCtD
Topotecan—Skin disorder—Methotrexate—lung cancer	1.03e-05	0.000262	CcSEcCtD
Topotecan—Hyperhidrosis—Methotrexate—lung cancer	1.03e-05	0.00026	CcSEcCtD
Topotecan—Malaise—Doxorubicin—lung cancer	1.02e-05	0.000258	CcSEcCtD
Topotecan—Anorexia—Methotrexate—lung cancer	1.01e-05	0.000257	CcSEcCtD
Topotecan—Leukopenia—Doxorubicin—lung cancer	1.01e-05	0.000256	CcSEcCtD
Topotecan—Diarrhoea—Docetaxel—lung cancer	1.01e-05	0.000256	CcSEcCtD
Topotecan—ABCG2—Transmembrane transport of small molecules—ABCC3—lung cancer	9.88e-06	0.000927	CbGpPWpGaD
Topotecan—Cough—Doxorubicin—lung cancer	9.84e-06	0.000249	CcSEcCtD
Topotecan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	9.8e-06	0.000919	CbGpPWpGaD
Topotecan—Dizziness—Docetaxel—lung cancer	9.75e-06	0.000247	CcSEcCtD
Topotecan—CYP3A4—Biological oxidations—GSTA4—lung cancer	9.7e-06	0.000909	CbGpPWpGaD
Topotecan—Musculoskeletal discomfort—Methotrexate—lung cancer	9.69e-06	0.000245	CcSEcCtD
Topotecan—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—lung cancer	9.68e-06	0.000907	CbGpPWpGaD
Topotecan—Arthralgia—Doxorubicin—lung cancer	9.6e-06	0.000243	CcSEcCtD
Topotecan—Chest pain—Doxorubicin—lung cancer	9.6e-06	0.000243	CcSEcCtD
Topotecan—Myalgia—Doxorubicin—lung cancer	9.6e-06	0.000243	CcSEcCtD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—lung cancer	9.59e-06	0.000899	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—GSTA4—lung cancer	9.57e-06	0.000897	CbGpPWpGaD
Topotecan—Paraesthesia—Methotrexate—lung cancer	9.55e-06	0.000242	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	9.54e-06	0.000242	CcSEcCtD
Topotecan—Discomfort—Doxorubicin—lung cancer	9.49e-06	0.00024	CcSEcCtD
Topotecan—ABCG2—Metabolism—ATP5H—lung cancer	9.48e-06	0.000889	CbGpPWpGaD
Topotecan—Dyspnoea—Methotrexate—lung cancer	9.48e-06	0.00024	CcSEcCtD
Topotecan—CYP3A4—Biological oxidations—GSTA2—lung cancer	9.45e-06	0.000886	CbGpPWpGaD
Topotecan—Vomiting—Docetaxel—lung cancer	9.38e-06	0.000238	CcSEcCtD
Topotecan—Dyspepsia—Methotrexate—lung cancer	9.36e-06	0.000237	CcSEcCtD
Topotecan—ABCB1—Allograft Rejection—CASP8—lung cancer	9.32e-06	0.000873	CbGpPWpGaD
Topotecan—Rash—Docetaxel—lung cancer	9.3e-06	0.000236	CcSEcCtD
Topotecan—Dermatitis—Docetaxel—lung cancer	9.29e-06	0.000235	CcSEcCtD
Topotecan—Decreased appetite—Methotrexate—lung cancer	9.24e-06	0.000234	CcSEcCtD
Topotecan—Headache—Docetaxel—lung cancer	9.24e-06	0.000234	CcSEcCtD
Topotecan—Anaphylactic shock—Doxorubicin—lung cancer	9.21e-06	0.000233	CcSEcCtD
Topotecan—Gastrointestinal disorder—Methotrexate—lung cancer	9.18e-06	0.000232	CcSEcCtD
Topotecan—Fatigue—Methotrexate—lung cancer	9.17e-06	0.000232	CcSEcCtD
Topotecan—Infection—Doxorubicin—lung cancer	9.15e-06	0.000232	CcSEcCtD
Topotecan—CYP3A4—Biological oxidations—GSTA1—lung cancer	9.12e-06	0.000855	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—APP—lung cancer	9.09e-06	0.000852	CbGpPWpGaD
Topotecan—Pain—Methotrexate—lung cancer	9.09e-06	0.00023	CcSEcCtD
Topotecan—Nervous system disorder—Doxorubicin—lung cancer	9.03e-06	0.000229	CcSEcCtD
Topotecan—Thrombocytopenia—Doxorubicin—lung cancer	9.01e-06	0.000228	CcSEcCtD
Topotecan—ABCG2—Transmembrane transport of small molecules—GNG11—lung cancer	8.96e-06	0.00084	CbGpPWpGaD
Topotecan—Skin disorder—Doxorubicin—lung cancer	8.94e-06	0.000226	CcSEcCtD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC22A18—lung cancer	8.92e-06	0.000836	CbGpPWpGaD
Topotecan—Hyperhidrosis—Doxorubicin—lung cancer	8.9e-06	0.000225	CcSEcCtD
Topotecan—Anorexia—Doxorubicin—lung cancer	8.77e-06	0.000222	CcSEcCtD
Topotecan—Nausea—Docetaxel—lung cancer	8.76e-06	0.000222	CcSEcCtD
Topotecan—Feeling abnormal—Methotrexate—lung cancer	8.76e-06	0.000222	CcSEcCtD
Topotecan—Gastrointestinal pain—Methotrexate—lung cancer	8.69e-06	0.00022	CcSEcCtD
Topotecan—CYP3A4—Metapathway biotransformation—AKR1C1—lung cancer	8.61e-06	0.000807	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—lung cancer	8.61e-06	0.000807	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—UGT1A1—lung cancer	8.48e-06	0.000795	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PLBD1—lung cancer	8.45e-06	0.000792	CbGpPWpGaD
Topotecan—Urticaria—Methotrexate—lung cancer	8.45e-06	0.000214	CcSEcCtD
Topotecan—Abdominal pain—Methotrexate—lung cancer	8.4e-06	0.000213	CcSEcCtD
Topotecan—Body temperature increased—Methotrexate—lung cancer	8.4e-06	0.000213	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Doxorubicin—lung cancer	8.39e-06	0.000212	CcSEcCtD
Topotecan—CYP3A4—Metapathway biotransformation—UGT1A1—lung cancer	8.36e-06	0.000784	CbGpPWpGaD
Topotecan—Paraesthesia—Doxorubicin—lung cancer	8.27e-06	0.000209	CcSEcCtD
Topotecan—Dyspnoea—Doxorubicin—lung cancer	8.21e-06	0.000208	CcSEcCtD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—AKT1—lung cancer	8.15e-06	0.000764	CbGpPWpGaD
Topotecan—Dyspepsia—Doxorubicin—lung cancer	8.1e-06	0.000205	CcSEcCtD
Topotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—lung cancer	8.07e-06	0.000756	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—ADCY1—lung cancer	8.06e-06	0.000755	CbGpPWpGaD
Topotecan—Decreased appetite—Doxorubicin—lung cancer	8e-06	0.000203	CcSEcCtD
Topotecan—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	7.95e-06	0.000745	CbGpPWpGaD
Topotecan—Gastrointestinal disorder—Doxorubicin—lung cancer	7.95e-06	0.000201	CcSEcCtD
Topotecan—Fatigue—Doxorubicin—lung cancer	7.94e-06	0.000201	CcSEcCtD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—JUN—lung cancer	7.91e-06	0.000741	CbGpPWpGaD
Topotecan—Pain—Doxorubicin—lung cancer	7.87e-06	0.000199	CcSEcCtD
Topotecan—Constipation—Doxorubicin—lung cancer	7.87e-06	0.000199	CcSEcCtD
Topotecan—Hypersensitivity—Methotrexate—lung cancer	7.83e-06	0.000198	CcSEcCtD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—lung cancer	7.82e-06	0.000733	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—HSD17B10—lung cancer	7.73e-06	0.000724	CbGpPWpGaD
Topotecan—Asthenia—Methotrexate—lung cancer	7.63e-06	0.000193	CcSEcCtD
Topotecan—Feeling abnormal—Doxorubicin—lung cancer	7.59e-06	0.000192	CcSEcCtD
Topotecan—Gastrointestinal pain—Doxorubicin—lung cancer	7.53e-06	0.000191	CcSEcCtD
Topotecan—Pruritus—Methotrexate—lung cancer	7.52e-06	0.000191	CcSEcCtD
Topotecan—ABCG2—Transmembrane transport of small molecules—TF—lung cancer	7.49e-06	0.000702	CbGpPWpGaD
Topotecan—CYP3A4—Tryptophan metabolism—MDM2—lung cancer	7.48e-06	0.000701	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—CXCL8—lung cancer	7.37e-06	0.00069	CbGpPWpGaD
Topotecan—Urticaria—Doxorubicin—lung cancer	7.31e-06	0.000185	CcSEcCtD
Topotecan—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	7.31e-06	0.000685	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—EP300—lung cancer	7.29e-06	0.000684	CbGpPWpGaD
Topotecan—Abdominal pain—Doxorubicin—lung cancer	7.28e-06	0.000184	CcSEcCtD
Topotecan—Body temperature increased—Doxorubicin—lung cancer	7.28e-06	0.000184	CcSEcCtD
Topotecan—Diarrhoea—Methotrexate—lung cancer	7.27e-06	0.000184	CcSEcCtD
Topotecan—CYP3A4—Biological oxidations—HPGDS—lung cancer	7.21e-06	0.000676	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CKB—lung cancer	7.18e-06	0.000674	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—CASP3—lung cancer	7.05e-06	0.000661	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—IL2—lung cancer	7.04e-06	0.00066	CbGpPWpGaD
Topotecan—Dizziness—Methotrexate—lung cancer	7.03e-06	0.000178	CcSEcCtD
Topotecan—CYP3A4—Biological oxidations—GSTT1—lung cancer	6.99e-06	0.000655	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—CYP2A6—lung cancer	6.91e-06	0.000648	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—GCLC—lung cancer	6.91e-06	0.000648	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—lung cancer	6.91e-06	0.000648	CbGpPWpGaD
Topotecan—Hypersensitivity—Doxorubicin—lung cancer	6.78e-06	0.000172	CcSEcCtD
Topotecan—Vomiting—Methotrexate—lung cancer	6.76e-06	0.000171	CcSEcCtD
Topotecan—ABCG2—Metabolism—GSTM2—lung cancer	6.75e-06	0.000633	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CNDP2—lung cancer	6.75e-06	0.000633	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—lung cancer	6.73e-06	0.00063	CbGpPWpGaD
Topotecan—Rash—Methotrexate—lung cancer	6.7e-06	0.00017	CcSEcCtD
Topotecan—Dermatitis—Methotrexate—lung cancer	6.7e-06	0.00017	CcSEcCtD
Topotecan—Headache—Methotrexate—lung cancer	6.66e-06	0.000169	CcSEcCtD
Topotecan—Asthenia—Doxorubicin—lung cancer	6.6e-06	0.000167	CcSEcCtD
Topotecan—ABCG2—Metabolism—MTMR3—lung cancer	6.57e-06	0.000616	CbGpPWpGaD
Topotecan—Pruritus—Doxorubicin—lung cancer	6.51e-06	0.000165	CcSEcCtD
Topotecan—ABCG2—Metabolism—PGAM1—lung cancer	6.4e-06	0.0006	CbGpPWpGaD
Topotecan—Nausea—Methotrexate—lung cancer	6.31e-06	0.00016	CcSEcCtD
Topotecan—Diarrhoea—Doxorubicin—lung cancer	6.3e-06	0.00016	CcSEcCtD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—lung cancer	6.18e-06	0.000579	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP2A7—lung cancer	6.11e-06	0.000573	CbGpPWpGaD
Topotecan—Dizziness—Doxorubicin—lung cancer	6.09e-06	0.000154	CcSEcCtD
Topotecan—ABCB1—Metabolism—AZIN2—lung cancer	6.03e-06	0.000565	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—COL4A3BP—lung cancer	6.03e-06	0.000565	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—VEGFA—lung cancer	5.98e-06	0.000561	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—SDC4—lung cancer	5.98e-06	0.00056	CbGpPWpGaD
Topotecan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	5.93e-06	0.000556	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—CYP2E1—lung cancer	5.88e-06	0.000551	CbGpPWpGaD
Topotecan—Vomiting—Doxorubicin—lung cancer	5.85e-06	0.000148	CcSEcCtD
Topotecan—Rash—Doxorubicin—lung cancer	5.8e-06	0.000147	CcSEcCtD
Topotecan—Dermatitis—Doxorubicin—lung cancer	5.8e-06	0.000147	CcSEcCtD
Topotecan—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	5.8e-06	0.000543	CbGpPWpGaD
Topotecan—Headache—Doxorubicin—lung cancer	5.77e-06	0.000146	CcSEcCtD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—lung cancer	5.69e-06	0.000533	CbGpPWpGaD
Topotecan—Nausea—Doxorubicin—lung cancer	5.47e-06	0.000139	CcSEcCtD
Topotecan—ABCG2—Metabolism—RRM1—lung cancer	5.44e-06	0.00051	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GSTA3—lung cancer	5.44e-06	0.00051	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—ABCC3—lung cancer	5.34e-06	0.000501	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—AVP—lung cancer	5.19e-06	0.000487	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ATP5H—lung cancer	5.13e-06	0.00048	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—B4GALT5—lung cancer	5.12e-06	0.00048	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—ABCB1—lung cancer	5.03e-06	0.000471	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GSTA4—lung cancer	4.98e-06	0.000467	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—APC—lung cancer	4.94e-06	0.000463	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	4.88e-06	0.000457	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GSTA2—lung cancer	4.85e-06	0.000455	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—GSTP1—lung cancer	4.85e-06	0.000454	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—GNG11—lung cancer	4.85e-06	0.000454	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	4.78e-06	0.000448	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GSTA1—lung cancer	4.68e-06	0.000439	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ABCC3—lung cancer	4.63e-06	0.000434	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	4.6e-06	0.000431	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	4.58e-06	0.000429	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PLBD1—lung cancer	4.57e-06	0.000428	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—AKR1C1—lung cancer	4.48e-06	0.00042	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—GSTM1—lung cancer	4.45e-06	0.000418	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—AKT1—lung cancer	4.41e-06	0.000413	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	4.39e-06	0.000412	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	4.37e-06	0.000409	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—ADCY1—lung cancer	4.36e-06	0.000408	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—ABCG2—lung cancer	4.36e-06	0.000408	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—UGT1A1—lung cancer	4.35e-06	0.000408	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—CYP1A1—lung cancer	4.22e-06	0.000396	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GNG11—lung cancer	4.2e-06	0.000393	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—HSD17B10—lung cancer	4.18e-06	0.000392	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	4.16e-06	0.00039	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—TF—lung cancer	4.05e-06	0.00038	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ALDOA—lung cancer	4e-06	0.000375	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—APOA1—lung cancer	3.97e-06	0.000372	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	3.89e-06	0.000364	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CKB—lung cancer	3.88e-06	0.000364	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—NCOA3—lung cancer	3.88e-06	0.000364	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	3.87e-06	0.000363	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	3.83e-06	0.000359	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ADCY1—lung cancer	3.77e-06	0.000354	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	3.75e-06	0.000351	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—AZIN2—lung cancer	3.71e-06	0.000348	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—COL4A3BP—lung cancer	3.71e-06	0.000348	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ENO2—lung cancer	3.7e-06	0.000347	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—HPGDS—lung cancer	3.7e-06	0.000347	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PPP2R1B—lung cancer	3.68e-06	0.000345	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CNDP2—lung cancer	3.65e-06	0.000342	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GSTM2—lung cancer	3.65e-06	0.000342	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GSTT1—lung cancer	3.59e-06	0.000337	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—MTMR3—lung cancer	3.55e-06	0.000333	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP2A6—lung cancer	3.55e-06	0.000333	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GCLC—lung cancer	3.55e-06	0.000333	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	3.48e-06	0.000326	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PGAM1—lung cancer	3.46e-06	0.000325	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	3.39e-06	0.000317	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	3.38e-06	0.000317	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ENO1—lung cancer	3.36e-06	0.000315	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—CREBBP—lung cancer	3.36e-06	0.000315	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP2A7—lung cancer	3.3e-06	0.00031	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	3.28e-06	0.000307	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	3.27e-06	0.000306	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SDC4—lung cancer	3.23e-06	0.000303	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ATP5H—lung cancer	3.16e-06	0.000296	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—POMC—lung cancer	3.15e-06	0.000295	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—ALB—lung cancer	3.15e-06	0.000295	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	3.12e-06	0.000292	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	3.03e-06	0.000284	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP2E1—lung cancer	3.02e-06	0.000283	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—NQO1—lung cancer	2.98e-06	0.00028	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	2.95e-06	0.000277	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—RRM1—lung cancer	2.94e-06	0.000276	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GSTA3—lung cancer	2.94e-06	0.000276	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—RAF1—lung cancer	2.85e-06	0.000267	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PLBD1—lung cancer	2.81e-06	0.000264	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—AVP—lung cancer	2.81e-06	0.000263	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	2.79e-06	0.000262	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—B4GALT5—lung cancer	2.77e-06	0.000259	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	2.72e-06	0.000255	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GSTA4—lung cancer	2.69e-06	0.000252	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—STK11—lung cancer	2.69e-06	0.000252	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	2.66e-06	0.000249	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GSTA2—lung cancer	2.62e-06	0.000246	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—HSD17B10—lung cancer	2.57e-06	0.000241	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GSTA1—lung cancer	2.53e-06	0.000237	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	2.51e-06	0.000235	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ABCC3—lung cancer	2.5e-06	0.000235	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GSTP1—lung cancer	2.49e-06	0.000233	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—AKR1C1—lung cancer	2.42e-06	0.000227	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CAT—lung cancer	2.42e-06	0.000227	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CKB—lung cancer	2.39e-06	0.000224	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ABCB1—lung cancer	2.36e-06	0.000221	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—UGT1A1—lung cancer	2.35e-06	0.000221	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—TYMS—lung cancer	2.31e-06	0.000217	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	2.31e-06	0.000216	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GSTM1—lung cancer	2.29e-06	0.000214	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GNG11—lung cancer	2.27e-06	0.000213	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GSTM2—lung cancer	2.25e-06	0.000211	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CNDP2—lung cancer	2.25e-06	0.000211	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	2.23e-06	0.000209	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—MTMR3—lung cancer	2.19e-06	0.000205	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP1A1—lung cancer	2.17e-06	0.000203	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ALDOA—lung cancer	2.16e-06	0.000203	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ERCC2—lung cancer	2.15e-06	0.000202	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	2.15e-06	0.000201	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PGAM1—lung cancer	2.13e-06	0.0002	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NCOA3—lung cancer	2.1e-06	0.000197	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ADCY1—lung cancer	2.04e-06	0.000191	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ABCG2—lung cancer	2.04e-06	0.000191	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP2A7—lung cancer	2.03e-06	0.000191	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ENO2—lung cancer	2e-06	0.000188	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—HPGDS—lung cancer	2e-06	0.000188	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SDC4—lung cancer	1.99e-06	0.000187	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PPP2R1B—lung cancer	1.99e-06	0.000186	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GSTT1—lung cancer	1.94e-06	0.000182	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GCLC—lung cancer	1.92e-06	0.00018	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP2A6—lung cancer	1.92e-06	0.00018	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	1.88e-06	0.000177	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—APOA1—lung cancer	1.86e-06	0.000174	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ENO1—lung cancer	1.82e-06	0.00017	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	1.82e-06	0.00017	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—RRM1—lung cancer	1.81e-06	0.00017	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GSTA3—lung cancer	1.81e-06	0.00017	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—B4GALT5—lung cancer	1.71e-06	0.00016	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	1.7e-06	0.000159	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PIK3CG—lung cancer	1.7e-06	0.000159	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GSTA4—lung cancer	1.66e-06	0.000156	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP2E1—lung cancer	1.63e-06	0.000153	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GSTA2—lung cancer	1.62e-06	0.000152	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—POMC—lung cancer	1.62e-06	0.000152	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NQO1—lung cancer	1.61e-06	0.000151	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CREBBP—lung cancer	1.57e-06	0.000148	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GSTA1—lung cancer	1.56e-06	0.000146	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ABCC3—lung cancer	1.54e-06	0.000145	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	1.54e-06	0.000144	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—AKR1C1—lung cancer	1.49e-06	0.00014	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PIK3CD—lung cancer	1.49e-06	0.00014	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ALB—lung cancer	1.47e-06	0.000138	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—STK11—lung cancer	1.45e-06	0.000136	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—UGT1A1—lung cancer	1.45e-06	0.000136	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GNG11—lung cancer	1.4e-06	0.000131	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GSTP1—lung cancer	1.35e-06	0.000126	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ALDOA—lung cancer	1.33e-06	0.000125	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CAT—lung cancer	1.31e-06	0.000123	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PIK3CB—lung cancer	1.3e-06	0.000122	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NCOA3—lung cancer	1.29e-06	0.000121	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PTGS2—lung cancer	1.29e-06	0.000121	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ADCY1—lung cancer	1.26e-06	0.000118	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ABCG2—lung cancer	1.26e-06	0.000118	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—TYMS—lung cancer	1.25e-06	0.000117	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GSTM1—lung cancer	1.24e-06	0.000116	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—HPGDS—lung cancer	1.23e-06	0.000116	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ENO2—lung cancer	1.23e-06	0.000116	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.23e-06	0.000115	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GSTT1—lung cancer	1.2e-06	0.000112	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP2A6—lung cancer	1.18e-06	0.000111	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GCLC—lung cancer	1.18e-06	0.000111	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP1A1—lung cancer	1.17e-06	0.00011	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ERCC2—lung cancer	1.16e-06	0.000109	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PTEN—lung cancer	1.12e-06	0.000105	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ENO1—lung cancer	1.12e-06	0.000105	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—EP300—lung cancer	1.07e-06	0.000101	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—APOA1—lung cancer	1.01e-06	9.43e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP2E1—lung cancer	1.01e-06	9.42e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NQO1—lung cancer	9.94e-07	9.32e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PIK3CG—lung cancer	9.18e-07	8.61e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—STK11—lung cancer	8.96e-07	8.4e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—POMC—lung cancer	8.74e-07	8.19e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CREBBP—lung cancer	8.51e-07	7.98e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GSTP1—lung cancer	8.29e-07	7.77e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PIK3CD—lung cancer	8.07e-07	7.57e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CAT—lung cancer	8.07e-07	7.56e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ALB—lung cancer	7.97e-07	7.47e-05	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PIK3CA—lung cancer	7.93e-07	7.43e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ABCB1—lung cancer	7.85e-07	7.36e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—TYMS—lung cancer	7.71e-07	7.22e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GSTM1—lung cancer	7.62e-07	7.14e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP1A1—lung cancer	7.22e-07	6.77e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ERCC2—lung cancer	7.16e-07	6.71e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PIK3CB—lung cancer	7.03e-07	6.59e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PTGS2—lung cancer	6.97e-07	6.53e-05	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—AKT1—lung cancer	6.48e-07	6.07e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—APOA1—lung cancer	6.19e-07	5.81e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PTEN—lung cancer	6.08e-07	5.7e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—EP300—lung cancer	5.8e-07	5.43e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PIK3CG—lung cancer	5.66e-07	5.3e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—POMC—lung cancer	5.38e-07	5.05e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CREBBP—lung cancer	5.24e-07	4.92e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PIK3CD—lung cancer	4.97e-07	4.66e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ALB—lung cancer	4.91e-07	4.6e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PIK3CB—lung cancer	4.33e-07	4.06e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PTGS2—lung cancer	4.29e-07	4.03e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PIK3CA—lung cancer	4.29e-07	4.02e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PTEN—lung cancer	3.74e-07	3.51e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—EP300—lung cancer	3.57e-07	3.35e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—AKT1—lung cancer	3.5e-07	3.28e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PIK3CA—lung cancer	2.64e-07	2.48e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—AKT1—lung cancer	2.16e-07	2.02e-05	CbGpPWpGaD
